Zimbabwe has successfully obtained an additional three-month supply of antiretroviral (ARV) drugs, ensuring a steady stock until September. This development comes after the US slashed $200 million in funding for HIV/AIDS programs, sparking concerns about potential shortages.
Health Minister Dr. Douglas Mombeshora reassured the nation that there are sufficient ARVs available, stating, “We have enough ARVs.” The government utilized the National AIDS Trust Fund, financed by a 3% tax on salaries, to purchase the new consignment. Dr. Mombeshora emphasized the importance of prioritizing ARVs, TB, and malaria medication, urging HIV patients to continue taking their medication as prescribed.
Foreign Affairs Minister Prof. Amon Murwira highlighted the need for Zimbabwe to focus on domestic funding solutions, stating, “Every country has the sovereign right to decide how it allocates aid.” The government is now relying more heavily on local funding sources, including:
– AIDS Levy: A 3% tax on salaries funding ARV drugs
– Mobile Health Levy: A 5% tax on airtime and data
– Sugar Tax: Imposed on sugary drinks to fund health equipment
Over 1.2 million Zimbabweans depend on ARVs, and the US had previously provided over $1.7 billion in funding since 2006 through PEPFAR. However, funding dropped by 30% under the Trump administration. Despite these cuts, the government asserts that no patient will go without treatment.
end//..
